1 – 12 of 12
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma
(
- Contribution to journal › Article
- 2021
-
Mark
Pain and functional outcomes in adult survivors of childhood cancer : A report from the St. Jude Lifetime Cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Neurocognitive and psychosocial outcomes in adult survivors of childhood soft-tissue sarcoma : A report from the St. Jude Lifetime Cohort
(
- Contribution to journal › Article
-
Mark
Sustainable care for children with cancer : a Lancet Oncology Commission
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Neurocognitive outcomes in long-term survivors of Wilms tumor : a report from the St. Jude Lifetime Cohort
(
- Contribution to journal › Article
-
Mark
Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma–identification of high-risk populations to guide surveillance : A report from the Late Effects Study Group
(
- Contribution to journal › Article
- 2016
-
Mark
GH Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
(
- Contribution to journal › Article
- 2015
-
Mark
Incidence of Primary Cancers and Intracranial Tumour Recurrences in Growth Hormone-Treated and Untreated Adult Hypopituitary Patients: Analyses from Hypopituitary Control and Complications Study
(
- Contribution to journal › Article
- 2013
-
Mark
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS
(
- Contribution to journal › Article
-
Mark
Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients.
(
- Contribution to journal › Article
- 2012
-
Mark
Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5-Year Survivors of Childhood Cancer.
2012) In Journal of Clinical Oncology(
- Contribution to journal › Article
- 2011
-
Mark
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study
(
- Contribution to journal › Article